Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting stent for LeFT main) Registry.

@article{Meliga2008LongestAC,
  title={Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting stent for LeFT main) Registry.},
  author={Emanuele Meliga and H. M. Garcia-Garcia and Marco Valgimigli and Alaide Chieffo and Giuseppe G. L. Biondi-Zoccai and Andrew O. Maree and Stephen C. Cook and Lindsay B. Reardon and Claudio Moretti and Stefano de Servi and Igor F. Palacios and Stephen Windecker and Antonio Colombo and Ron Theodoor van Domburg and Imad Sheiban and Patrick Washington Serruys},
  journal={Journal of the American College of Cardiology},
  year={2008},
  volume={51 23},
  pages={2212-9}
}
OBJECTIVES The purpose of this study was to investigate the long-term safety and efficacy of percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation for unprotected left main coronary artery (ULMCA) disease. BACKGROUND Long-term clinical outcomes after DES implantation for ULMCA disease have not yet been ascertained. METHODS From April 2002 to April 2004, 358 consecutive patients who underwent PCI with DES implantation for de novo lesions on ULMCA were… CONTINUE READING